Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (221-230 of 393) with videos related to

Pageof 40
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2016
Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic DerangementChristopher Low, Daneyal Syed, Daniel Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 1, 2022
The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism PatientsBulent Kantarcioglu, Amir Darki, Fakiha Siddiqui, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitusSibel Guldiken, Burhan Turgut, Muzaffer Demir, et al.
Thrombosis Research|November 5, 2017
Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activationKeita Osada, Tatsuro Minami, Takashi Arioka, et al.
The Journal of Rheumatology|February 12, 2009
Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue diseasesGiuseppe Cella, Fabrizio Vianello, Franco Cozzi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 26, 2007
Potential thrombogenic complications with the use of recombinant activated factor VII in combat traumaJawed Fareed, Rodger L Bick, Craig Kessler, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 30, 2013
Compositional differences in commercially available prothrombin complex concentratesNasir Sadeghi, Daniel Kahn, Daneyal Sayed, et al.
Transfusion|December 17, 2009
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosisJonathan R Genzen, Jawed Fareed, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 28, 2017
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jeffrey Liles, Elissa Finkler, et al.
Pageof 40

Showing results (221-230 of 393) with videos related to

Sort By:
Pageof 40
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2016
Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic DerangementChristopher Low, Daneyal Syed, Daniel Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 1, 2022
The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism PatientsBulent Kantarcioglu, Amir Darki, Fakiha Siddiqui, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitusSibel Guldiken, Burhan Turgut, Muzaffer Demir, et al.
Thrombosis Research|November 5, 2017
Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activationKeita Osada, Tatsuro Minami, Takashi Arioka, et al.
The Journal of Rheumatology|February 12, 2009
Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue diseasesGiuseppe Cella, Fabrizio Vianello, Franco Cozzi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 26, 2007
Potential thrombogenic complications with the use of recombinant activated factor VII in combat traumaJawed Fareed, Rodger L Bick, Craig Kessler, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 30, 2013
Compositional differences in commercially available prothrombin complex concentratesNasir Sadeghi, Daniel Kahn, Daneyal Sayed, et al.
Transfusion|December 17, 2009
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosisJonathan R Genzen, Jawed Fareed, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 28, 2017
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jeffrey Liles, Elissa Finkler, et al.
Pageof 40